Vimarsana
Biggest News Aggregation in the World

Enrollment Completed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Enrollment Completed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Enrollment Completed Today - Breaking & Trending Today

SELLAS Announces Positive Topline Data from the Phase 2a Study of SLS009 in r/r AML and ... - Vimarsana News

SELLAS Announces Positive Topline Data from the Phase 2a Study of SLS009 in r/r AML and ...

- Phase 3 REGAL Study of GPS in AML: Enrollment Completed; Steering Committee Guided Interim Analysis Imminent; IDMC Now Scheduled in Late April-

SELLAS Announces Positive Topline Data from the Phase 2a - Vimarsana News

SELLAS Announces Positive Topline Data from the Phase 2a

- Phase 3 REGAL Study of GPS in AML: Enrollment Completed; Steering Committee Guided Interim Analysis Imminent; IDMC Now Scheduled in Late April - - Phase...

Spruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates - Vimarsana News

Spruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

Enrollment Completed in CAHptain-205 Study in Pediatric Classic Congenital Adrenal Hyperplasia (CAH)Target Enrollment Completed in CAHmelia-203 Study in Adult Classic CAHCAHmelia-204 Study in Adult Classic CAH on Track to Complete Enrollment in Early Q1 2024SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosci...

Verastem Oncology Reports First Quarter 2022 Financial Results and Highlights Recent Company Progres - Vimarsana News

Verastem Oncology Reports First Quarter 2022 Financial Results and Highlights Recent Company Progres

Enrollment Completed in Selection Phases (Part A) of RAMP 201 and RAMP 202 Evaluating VS-6766 +/- Defactinib for the Treatment of Low-Grade Serous Ovarian Cancer and KRAS G12V Mutant Non-Small Cell Lung CancerCompany Secured up to $150 Million in Non-Dilutive Funding from Oxford Finance LLC; Expected Cash Runway Thr...

ReCor Medical's RADIANCE-II Pivotal Trial of Paradise uRDN System Completes Enrollment - Vimarsana News

ReCor Medical's RADIANCE-II Pivotal Trial of Paradise uRDN System Completes Enrollment

March 29, 2022—ReCor Medical, Inc., a fully owned subsidiary of Otsuka Medical Devices Co., Ltd., announced completion of enrollment in the RADI